Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae

VH Tam, PR Merlau, CS Hudson… - Journal of …, 2022 - academic.oup.com
Objectives Infections due to carbapenem-resistant Enterobacterales are considered urgent
public health threats and often treated with a β-lactam/β-lactamase inhibitor combination …

[HTML][HTML] In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii

N Pouya, JE Smith, CS Hudson, NS Teran… - Journal of Global …, 2024 - Elsevier
Abstract Objective Carbapenem-resistant Acinetobacter baumannii (CRAB) is a global
concern as effective treatments are very limited. We previously used a modified susceptibility …